4588 — Oncolys Biopharma Share News
0.000.00%
Last trade - 00:00- ¥175bn
- ¥173bn
- ¥29m
Brief: Oncolys BioPharma invests in US Biotech Venture Specialized in Development of Novel Oncolytic Adenovirus
Table: Oncolys Biopharma -2017 parent results
Table: Oncolys Biopharma -2017 parent forecast
Brief: Oncolys Biopharma says joint research agreement with Juntendo University
Table: Oncolys Biopharma - 9-MTH parent results
Table: Oncolys Biopharma - 6-MTH parent results
Brief: Oncolys Biopharma says exercise of options
Brief: Oncolys BioPharma says first patient enrolled into Telomelysin Phase I clinical trial
Brief: Oncolys Biopharma announces exercise of options
Brief: Oncolys Biopharma announces exercise of options
Brief: Oncolys Biopharma says exercise of options
Table: Oncolys Biopharma - Q1 parent results
Brief: Oncolys Biopharma says exercise of options
Brief: Oncolys BioPharma plans capital alliance with bio firm in vaccine business
Brief: Oncolys Biopharma signs joint research agreement for next generation telomelysin with Osaka University
Table: Oncolys Biopharma -2016 parent results
Brief: Jiangsu Hengrui Medicine in licensing agreement with Japan's Oncolys Biopharma
Brief: Oncolys BioPharma signs exclusive license agreement with Jiangsu Hengrui Medicine on OBP-301 in China
Table: Oncolys Biopharma -9-MTH parent results